Provided by Tiger Trade Technology Pte. Ltd.

Co-Diagnostics, Inc.

0.9408
-0.1992-17.47%
Post-market: 0.9400-0.0008-0.09%16:31 EDT
Volume:1.53M
Turnover:1.59M
Market Cap:6.57M
PE:-0.04
High:1.10
Open:1.10
Low:0.9300
Close:1.14
52wk High:46.50
52wk Low:0.9300
Shares:6.98M
Float Shares:6.86M
Volume Ratio:9.60
T/O Rate:22.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-23.8424
EPS(LYR):-37.2229
ROE:-174.77%
ROA:-59.63%
PB:0.52
PE(LYR):-0.03

Loading ...

NASDAQ Trade Halt Volatility Trading Pause at 09:40 Am

Reuters
·
Jul 01

Co-diagnostics Completes Studies Ahead of Planned Q3 2026 FDA Filing for Flu/rsv Point-of-care PCR Test

Reuters
·
Jul 01

Co-diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-care Test

THOMSON REUTERS
·
Jul 01

Co-Diagnostics hosts Saudi joint venture CoMira for automated manufacturing line unveiling in Utah

Reuters
·
Jun 18

Co-Diagnostics Signs Exclusive Distribution Deal With Mexican Partner; Shares Rise Pre-Bell

MT Newswires Live
·
Jun 11

Co-Diagnostics signs exclusive Mexico distribution deal for Co-Dx PCR Pro platform

Reuters
·
Jun 11

Co-Diagnostics - Agreement Grants Exclusive Distribution Rights in Mexico and Extends for Five Years

THOMSON REUTERS
·
Jun 11

Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ Pcr Pro® With Mexico Distributor Agreement

THOMSON REUTERS
·
Jun 11

Co-Diagnostics announces continued progress in Ebola PCR development program

TIPRANKS
·
Jun 02

Co-Diagnostics trading resumes

TIPRANKS
·
Jun 02

Co-Diagnostics and Cosara Advance Ebola Pcr Test Development and Co-Dx™ Pcr Point-of-Care Platform Capabilities

THOMSON REUTERS
·
Jun 02

Co-Diagnostics advances pan-Ebola, multiplex PCR test development with CoSara JV

Reuters
·
Jun 02

Co-Diagnostics files to sell 4.94M shares of common stock for holders

TIPRANKS
·
May 29

Co-Diagnostics trading resumes

TIPRANKS
·
May 27

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:59 AM

Reuters
·
May 27

Top Midday Gainers

MT Newswires Live
·
May 27

Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development

TIPRANKS
·
May 26

Co-Diagnostics, CoSara plan Bundibugyo Ebola PCR assay program for global deployment

Reuters
·
May 26

Co-Diagnostics Advances Ebola Pcr Assay Development Strategy With Joint Venture Cosara

THOMSON REUTERS
·
May 26

Top Premarket Gainers

MT Newswires Live
·
May 21